Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

23 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Eligibility Cancer NCT01162551

- 21/12/2015 - 1 Formulaire, 2 Groupes Item, 19 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01162551

CALGB-10501 Concerns About Cancer Progression Form NCT00513747

- 18/06/2015 - 1 Formulaire, 4 Groupes Item, 18 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Concerns About Cancer Assessment, Footer Module
CALGB-10501 Concerns About Cancer Progression Form NCT00513747 Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=340EDF8E-59EA-1F88-E044-0003BA3F9857

Eligibility Leukemia NCT02193100

- 25/06/2020 - 1 Formulaire, 2 Groupes Item, 15 Eléments de données, 1 Langue
Groupes Item: Criteria, Exclusion Criteria
Pre and Post Treatment Metabolomic Analysis of Leukemia: A Translational Clinical Trial of the Brown Cancer Center; ODM derived from: https://clinicaltrials.gov/show/NCT02193100

Eligibility Leukemia NCT00897182

- 19/05/2018 - 1 Formulaire, 1 Groupe Item, 11 Eléments de données, 1 Langue
Groupe Item: Criteria
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00897182

ABTR01B1: Eligibility NCT00898079

- 03/07/2015 - 1 Formulaire, 3 Groupes Item, 9 Eléments de données, 1 Langue
Groupes Item: Header, Eligibility Assessment, CCRR MODULE
ABTR01B1: Eligibility NCT00898079 Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BCEF5AA5-5C2A-372E-E034-0003BA12F5E7

ABTR01B1: On Study Worksheet NCT00898079

- 03/07/2015 - 1 Formulaire, 3 Groupes Item, 17 Eléments de données, 1 Langue
Groupes Item: Header, Miscellaneous Patient Information, CCRR MODULE
ABTR01B1: On Study Worksheet NCT00898079 Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C08BFA5F-2EAD-673E-E034-0003BA12F5E7

Death Worksheet [ABTR01B1] NCT00898079

- 21/06/2015 - 1 Formulaire, 3 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: Header, Death Assessment, CCRR MODULE
Death Worksheet [ABTR01B1] NCT00898079 Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BCEF6DCD-9661-3744-E034-0003BA12F5E7

Relapse/Progression [ABTR01B1] NCT00898079

- 03/06/2015 - 1 Formulaire, 3 Groupes Item, 11 Eléments de données, 1 Langue
Groupes Item: Header Module, Relapse/progression status, CCRR MODULE
Relapse/Progression [ABTR01B1] Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer NCT00898079 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BCEF65B1-5B3C-3739-E034-0003BA12F5E7

ABTR01B1: Specimen Shipping Form NCT00898079

- 03/07/2015 - 1 Formulaire, 5 Groupes Item, 30 Eléments de données, 1 Langue
Groupes Item: Header, Disease / Patient Status, Shipping Information, Patient Status Information, CCRR MODULE
ABTR01B1: Specimen Shipping Form NCT00898079 Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BCEE8B04-749D-37DA-E034-0003BA12F5E7

Leukemia NCT00898079 Follow-Up - Off Protocol Therapy Follow-up (OPTF) Report [ABTR01B1] - 2172125v3.0 - Off Protocol Therapy Follow-up (OPTF) Report [ABTR01B1]

- 09/01/2015 - 1 Formulaire, 4 Groupes Item, 23 Eléments de données, 1 Langue
Groupes Item: Header, Patient Status Information, Events of Interest., CCRR MODULE
Off Protocol Therapy Follow-up (OPTF) Report [ABTR01B1] Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C0DB9E9B-20A9-68CC-E034-0003BA12F5E7

dbGaP phs001066 DNA and RNA Sequence of an Acute Lymphoblastic Leukemia - pht005280.v1.p1

- 23/06/2023 - 4 Formulaires, 1 Groupe Item, 3 Eléments de données, 1 Langue
Groupe Item: pht005280
Principal Investigator: Richard K. Wilson, PhD, McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA MeSH: Neoplasms,Leukemia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001066 We used massively parallel sequencing technology to profile the genomic DNA and RNA of tumor cells (leukemic bone marrow) and normal cells (skin biopsy) obtained from a single patient with Acute Lymphoblastic Leukemia (ALL), referred to throughout this study as 'ALL1'. Included in this study are samples obtained from a primary tumor, first relapse, second relapse and several intermediate timepoints. We identified somatic mutations present in each tumor by analysis of whole genome (WGS) and exome sequence data. Single nucleotide variants (SNVs) and small insertions and deletions were identified in both the exome and WGS data. Large copy number variations (CNVs) and structural variants (SVs) were identified in the WGS data. A custom capture reagent was designed to target most variants and used to generate deep validation sequence data. The expression status of all somatic variants was assessed by RNA-seq. The RNA-seq data was also used for gene expression analysis and gene fusion detection.

pht005281.v1.p1

1 Groupe Item 3 Eléments de données

pht005282.v1.p1

1 Groupe Item 2 Eléments de données

pht005283.v1.p1

1 Groupe Item 5 Eléments de données

E2905 Second Primary Form NCT00843882

- 16/06/2015 - 1 Formulaire, 5 Groupes Item, 22 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Data amendment, Second primary cancer assessment, Comments
E2905 Second Primary Form NCT00843882 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0EAAC99D-1E15-00B1-E044-0003BA3F9857

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial